O	O	O	0	11	Involvement	Involvement	B-NP	NN	O	0	ROOT	O
O	O	O	12	14	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	15	28	intracellular	intracellular	B-NP	JJ	B-protein	4	NMOD	B-protein
O	O	O	29	32	Ca2	Ca2	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	32	33	+	+	B-NP	SYM	O	4	NMOD	O
O	O	O	34	36	in	in	B-PP	IN	O	5	PRD	O
O	O	O	37	44	oxidant	oxidant	B-NP	NN	O	14	NMOD	O
O	O	O	44	45	-	-	O	HYPH	O	14	P	O
O	O	O	45	52	induced	induce	B-NP	VBN	O	14	NMOD	O
T1	B-Entity	B-Entity	53	55	NF	NF	I-NP	NN	B-protein	14	NMOD	B-protein
T1	I-Entity	I-Entity	55	56	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T1	I-Entity	I-Entity	56	61	kappa	kappa	I-NP	NN	I-protein	14	NMOD	I-protein
T1	I-Entity	I-Entity	62	63	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	64	74	activation	activation	I-NP	NN	O	6	PMOD	O
O	O	O	74	75	.	.	O	.	O	1	P	O

O	O	O	77	79	In	In	B-PP	IN	O	0	ROOT	O
O	O	O	80	85	human	human	B-NP	JJ	B-cell_line	5	NMOD	B-cell_line
O	O	O	86	92	Jurkat	Jurkat	I-NP	NN	I-cell_line	5	NMOD	I-cell_line
O	O	O	93	94	T	T	I-NP	NN	I-cell_line	5	NMOD	I-cell_line
O	O	O	95	100	cells	cell	I-NP	NNS	I-cell_line	10	NMOD	I-cell_line
O	O	O	101	104	and	and	O	CC	O	10	NMOD	O
O	O	O	105	108	its	its	B-NP	PRP$	O	8	NMOD	O
O	O	O	109	117	subclone	subclone	I-NP	NN	O	10	NMOD	O
O	O	O	118	126	Wurzburg	Wurzburg	I-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	O	127	132	cells	cell	I-NP	NNS	I-cell_line	1	PMOD	I-cell_line
O	O	O	133	140	oxidant	oxidant	I-NP	NN	O	12	NMOD	O
O	O	O	141	150	challenge	challenge	I-NP	NN	O	1	PMOD	O
O	O	O	151	159	elevated	elevate	B-VP	VBN	O	12	NMOD	O
O	O	O	160	161	[	[	O	(	O	17	DEP	O
O	O	O	161	164	Ca2	Ca2	O	NN	B-protein	17	DEP	B-protein
O	O	O	164	165	+	+	O	SYM	O	17	DEP	O
O	O	O	165	166	]	]	O	)	O	12	NMOD	O
O	O	O	166	167	i	i	B-NP	NN	O	1	PMOD	O
O	O	O	168	170	by	by	B-PP	IN	O	1	PMOD	O
O	O	O	171	181	mobilizing	mobilize	B-VP	VBG	O	19	PMOD	O
O	O	O	182	185	Ca2	Ca2	B-NP	NN	B-protein	20	OBJ	B-protein
O	O	O	185	186	+	+	B-ADJP	SYM	O	21	NMOD	O
O	O	O	187	191	from	from	B-PP	IN	O	22	AMOD	O
O	O	O	192	205	intracellular	intracellular	B-NP	JJ	O	25	NMOD	O
O	O	O	206	212	stores	store	I-NP	NNS	O	23	PMOD	O
O	O	O	212	213	.	.	O	.	O	1	P	O

O	O	O	214	216	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	217	223	Jurkat	Jurkat	B-NP	NN	B-cell_line	3	NMOD	B-cell_line
O	O	O	224	229	cells	cell	I-NP	NNS	I-cell_line	1	PMOD	I-cell_line
O	O	O	230	234	this	this	B-NP	DT	O	5	NMOD	O
O	O	O	235	241	effect	effect	I-NP	NN	O	6	SUB	O
O	O	O	242	245	was	be	B-VP	VBD	O	17	VMOD	O
O	O	O	246	251	rapid	rapid	B-ADJP	JJ	O	9	AMOD	O
O	O	O	252	255	and	and	I-ADJP	CC	O	9	AMOD	O
O	O	O	256	265	transient	transient	I-ADJP	JJ	O	6	PRD	O
O	O	O	265	266	,	,	O	,	O	17	P	O
O	O	O	267	270	but	but	O	CC	O	17	VMOD	O
O	O	O	271	273	in	in	B-PP	IN	O	17	VMOD	O
O	O	O	274	282	Wurzburg	Wurzburg	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	283	288	cells	cell	I-NP	NNS	I-cell_line	12	PMOD	I-cell_line
O	O	O	289	292	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	293	301	response	response	I-NP	NN	O	17	SUB	O
O	O	O	302	305	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	306	310	slow	slow	B-ADJP	JJ	O	20	AMOD	O
O	O	O	311	314	and	and	I-ADJP	CC	O	20	AMOD	O
O	O	O	315	324	sustained	sustained	I-ADJP	JJ	O	17	PRD	O
O	O	O	324	325	.	.	O	.	O	17	P	O

O	O	O	326	330	H2O2	H2O2	B-NP	NN	O	7	NMOD	O
O	O	O	330	331	-	-	B-PP	HYPH	O	1	P	O
O	O	O	331	338	induced	induce	B-NP	VBN	O	7	NMOD	O
T2	B-Entity	B-Entity	339	341	NF	NF	I-NP	NN	B-protein	6	NMOD	B-protein
T2	I-Entity	I-Entity	341	342	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T2	I-Entity	I-Entity	342	348	kappaB	kappaB	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	O	349	359	activation	activation	I-NP	NN	O	11	SUB	O
O	O	O	360	362	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	363	371	Wurzburg	Wurzburg	B-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	O	372	377	cells	cell	I-NP	NNS	I-cell_line	8	PMOD	I-cell_line
O	O	O	378	381	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	382	385	not	not	I-VP	RB	O	11	VMOD	O
O	O	O	386	396	influenced	influence	I-VP	VBN	O	11	VC	O
O	O	O	397	399	by	by	B-PP	IN	O	13	VMOD	O
O	O	O	400	403	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	404	412	presence	presence	I-NP	NN	O	14	PMOD	O
O	O	O	413	415	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	416	429	extracellular	extracellular	B-NP	JJ	O	19	NMOD	O
O	O	O	430	434	EGTA	EGTA	I-NP	NN	O	17	PMOD	O
O	O	O	435	438	but	but	O	CC	O	11	VMOD	O
O	O	O	439	442	was	be	B-VP	VBD	O	11	VMOD	O
O	O	O	443	450	totally	totally	I-VP	RB	O	21	VMOD	O
O	O	O	451	460	inhibited	inhibit	I-VP	VBN	O	21	VC	O
O	O	O	461	463	in	in	B-PP	IN	O	23	VMOD	O
O	O	O	464	469	cells	cell	B-NP	NNS	O	24	PMOD	O
O	O	O	470	474	that	that	B-NP	WDT	O	25	NMOD	O
O	O	O	475	479	were	be	B-VP	VBD	O	26	SBAR	O
O	O	O	480	486	loaded	load	I-VP	VBN	O	27	VC	O
O	O	O	487	491	with	with	B-PP	IN	O	28	VMOD	O
O	O	O	492	502	esterified	esterify	B-NP	VBN	O	31	NMOD	O
O	O	O	503	507	EGTA	EGTA	I-NP	NN	O	29	PMOD	O
O	O	O	507	508	.	.	O	.	O	11	P	O

O	O	O	509	511	In	In	B-PP	IN	O	18	VMOD	O
O	O	O	512	518	Jurkat	Jurkat	B-NP	NN	B-cell_line	3	NMOD	B-cell_line
O	O	O	519	524	cells	cell	I-NP	NNS	I-cell_line	1	PMOD	I-cell_line
O	O	O	525	529	that	that	B-NP	WDT	O	3	NMOD	O
O	O	O	530	533	are	be	B-VP	VBP	O	4	SBAR	O
O	O	O	534	537	not	not	O	RB	O	5	VMOD	O
O	O	O	538	547	sensitive	sensitive	B-ADJP	JJ	O	5	PRD	O
O	O	O	548	550	to	to	B-PP	TO	O	7	AMOD	O
O	O	O	551	555	H2O2	H2O2	B-NP	NN	O	15	NMOD	O
O	O	O	555	556	-	-	O	HYPH	O	9	P	O
O	O	O	556	563	induced	induce	B-NP	VBN	O	15	NMOD	O
T3	B-Entity	B-Entity	564	566	NF	NF	I-NP	NN	B-protein	15	NMOD	B-protein
T3	I-Entity	I-Entity	566	567	-	-	O	HYPH	I-protein	15	NMOD	I-protein
T3	I-Entity	I-Entity	567	573	kappaB	kappaB	B-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	574	584	activation	activation	I-NP	NN	O	8	PMOD	O
O	O	O	584	585	,	,	O	,	O	18	P	O
O	O	O	586	590	H2O2	H2O2	B-NP	NN	O	18	SUB	O
O	O	O	591	602	potentiated	potentiate	B-VP	VBD	O	0	ROOT	O
T4	B-Entity	B-Entity	603	605	NF	NF	B-NP	NN	B-protein	21	NMOD	B-protein
T4	I-Entity	I-Entity	605	606	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T4	I-Entity	I-Entity	606	612	kappaB	kappaB	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	O	613	623	activation	activation	I-NP	NN	O	18	OBJ	O
O	O	O	624	626	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	627	630	the	the	I-PP	DT	O	25	NMOD	O
O	O	O	631	639	presence	presence	I-PP	NN	O	23	PMOD	O
O	O	O	640	642	of	of	I-PP	IN	O	25	NMOD	O
O	O	O	643	652	sustained	sustained	B-NP	JJ	O	28	AMOD	O
O	O	O	653	657	high	high	I-NP	JJ	O	26	PMOD	O
O	O	O	658	659	[	[	O	(	O	32	DEP	O
O	O	O	659	662	Ca2	Ca2	O	NN	B-protein	32	DEP	B-protein
O	O	O	662	663	+	+	O	SYM	O	32	DEP	O
O	O	O	663	664	]	]	O	)	O	28	NMOD	O
O	O	O	664	665	i	i	B-NP	NN	O	28	NMOD	O
O	O	O	666	675	following	follow	B-PP	VBG	O	28	NMOD	O
O	O	O	676	688	thapsigargin	thapsigargin	B-NP	NN	O	36	NMOD	O
O	O	O	689	698	treatment	treatment	I-NP	NN	O	34	PMOD	O
O	O	O	698	699	.	.	O	.	O	18	P	O

T5	B-Entity	B-Entity	700	702	NF	NF	B-NP	NN	B-protein	3	NMOD	B-protein
T5	I-Entity	I-Entity	702	703	-	-	I-NP	HYPH	I-protein	3	P	I-protein
T5	I-Entity	I-Entity	703	709	kappaB	kappaB	I-NP	NN	I-protein	5	NMOD	I-protein
O	O	O	710	720	regulatory	regulatory	I-NP	JJ	O	5	NMOD	O
O	O	O	721	727	effect	effect	I-NP	NN	O	14	SUB	O
O	O	O	728	730	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	731	736	alpha	alpha	B-NP	SYM	O	13	NMOD	O
O	O	O	736	737	-	-	I-NP	HYPH	O	13	NMOD	O
O	O	O	737	744	lipoate	lipoate	I-NP	NN	O	13	NMOD	O
O	O	O	745	748	and	and	I-NP	CC	O	13	NMOD	O
T6	B-Entity	B-Entity	749	750	N	N	I-NP	NN	O	13	NMOD	O
T6	I-Entity	I-Entity	750	751	-	-	B-NP	HYPH	O	13	NMOD	O
T6	I-Entity	I-Entity	751	765	acetylcysteine	acetylcysteine	I-NP	NN	O	6	PMOD	O
O	O	O	766	774	appeared	appear	B-VP	VBD	O	0	ROOT	O
O	O	O	775	777	to	to	I-VP	TO	O	16	VMOD	O
O	O	O	778	780	be	be	I-VP	VB	O	14	VMOD	O
O	O	O	780	781	,	,	O	,	O	16	P	O
O	O	O	782	784	at	at	B-ADVP	IN	O	20	PMOD	O
O	O	O	785	790	least	least	I-ADVP	JJS	O	18	AMOD	O
O	O	O	791	793	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	794	798	part	part	B-NP	NN	O	20	PMOD	O
O	O	O	798	799	,	,	O	,	O	16	P	O
O	O	O	800	803	due	due	B-PP	IN	O	16	PRD	O
O	O	O	804	806	to	to	I-PP	TO	O	23	AMOD	O
O	O	O	807	812	their	their	B-NP	PRP$	O	26	NMOD	O
O	O	O	813	820	ability	ability	I-NP	NN	O	24	PMOD	O
O	O	O	821	823	to	to	B-VP	TO	O	28	VMOD	O
O	O	O	824	833	stabilize	stabilize	I-VP	VB	O	26	NMOD	O
O	O	O	834	843	elevation	elevation	B-NP	NN	O	28	OBJ	O
O	O	O	844	846	of	of	B-PP	IN	O	29	NMOD	O
O	O	O	847	848	[	[	O	(	O	34	DEP	O
O	O	O	848	851	Ca2	Ca2	O	NN	B-protein	34	DEP	B-protein
O	O	O	851	852	+	+	O	SYM	O	34	DEP	O
O	O	O	852	853	]	]	O	)	O	35	NMOD	O
O	O	O	853	854	i	i	B-NP	NN	O	30	PMOD	O
O	O	O	855	864	following	follow	B-PP	VBG	O	28	VMOD	O
O	O	O	865	872	oxidant	oxidant	B-NP	JJ	O	38	NMOD	O
O	O	O	873	882	challenge	challenge	I-NP	NN	O	36	PMOD	O
O	O	O	882	883	.	.	O	.	O	14	P	O

O	O	O	884	891	Results	Result	B-NP	NNS	O	5	SUB	O
O	O	O	892	894	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	895	899	this	this	B-NP	DT	O	4	NMOD	O
O	O	O	900	905	study	study	I-NP	NN	O	2	PMOD	O
O	O	O	906	914	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	915	919	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	O	920	921	a	a	B-NP	DT	O	14	NMOD	O
O	O	O	922	931	sustained	sustain	I-NP	VBN	O	9	AMOD	O
O	O	O	932	940	elevated	elevate	I-NP	VBN	O	14	NMOD	O
O	O	O	941	942	[	[	I-NP	(	O	14	NMOD	O
O	O	O	942	945	Ca2	Ca2	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	945	946	+	+	O	SYM	O	14	NMOD	O
O	O	O	946	947	]	]	O	)	O	14	NMOD	O
O	O	O	947	948	i	i	B-NP	NN	O	15	SUB	O
O	O	O	949	951	is	be	B-VP	VBZ	O	6	SBAR	O
O	O	O	952	953	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	954	965	significant	significant	I-NP	JJ	O	18	NMOD	O
O	O	O	966	972	factor	factor	I-NP	NN	O	15	PRD	O
O	O	O	973	975	in	in	B-PP	IN	O	18	NMOD	O
O	O	O	976	983	oxidant	oxidant	B-NP	NN	O	26	NMOD	O
O	O	O	983	984	-	-	O	HYPH	O	26	NMOD	O
O	O	O	984	991	induced	induce	B-NP	VBN	O	26	NMOD	O
T7	B-Entity	B-Entity	992	994	NF	NF	I-NP	NN	B-protein	25	NMOD	B-protein
T7	I-Entity	I-Entity	994	995	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T7	I-Entity	I-Entity	995	1001	kappaB	kappaB	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	1002	1012	activation	activation	I-NP	NN	O	19	PMOD	O
O	O	O	1012	1013	.	.	O	.	O	5	P	O
